Clinical Trial Update: Multicenter Evaluation of Memory Remediation After TBI With Donepezil [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating memory remediation after traumatic brain injury with donepezil has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Donepezil (Aricept) (Donepezil)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Traumatic Brain Injury, Memory Deficits | Phase 3 | Status: COMPLETED